Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma.

Sun G, Tian J, Gorospe EC, Johnson GB, Hunt CH, Lutzke LS, Leggett CL, Iyer PG, Wang KK.

J Gastroenterol Hepatol. 2013 Jun;28(6):975-81. doi: 10.1111/jgh.12148.

PMID:
23425230
2.

The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.

Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L.

J Thorac Cardiovasc Surg. 2000 Dec;120(6):1085-92.

PMID:
11088030
3.

Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.

Sasada S, Miyata Y, Tsubokawa N, Mimae T, Yoshiya T, Okada M.

Ann Thorac Surg. 2014 Aug;98(2):417-22. doi: 10.1016/j.athoracsur.2014.04.080. Epub 2014 Jun 21.

PMID:
24961842
4.

Outcomes of T1b esophageal adenocarcinoma patients.

Tian J, Prasad GA, Lutzke LS, Lewis JT, Wang KK.

Gastrointest Endosc. 2011 Dec;74(6):1201-6. doi: 10.1016/j.gie.2011.08.006. Epub 2011 Oct 13. Erratum in: Gastrointest Endosc. 2012 Feb;75(2):465.

PMID:
22000793
5.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458
7.

Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis?

Cervino AR, Evangelista L, Alfieri R, Castoro C, Sileni VC, Pomerri F, Corti L, Muzzio PC.

J Cancer Res Ther. 2012 Oct-Dec;8(4):619-25. doi: 10.4103/0973-1482.106580.

PMID:
23361284
8.

The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.

Pfau PR, Perlman SB, Stanko P, Frick TJ, Gopal DV, Said A, Zhang Z, Weigel T.

Gastrointest Endosc. 2007 Mar;65(3):377-84.

PMID:
17321235
9.

PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.

Lindner K, Palmes D, Senninger N, Hummel R.

Langenbecks Arch Surg. 2015 Feb;400(2):229-35. doi: 10.1007/s00423-014-1264-9. Epub 2015 Jan 9.

PMID:
25572665
10.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
11.

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, Rusch V.

Ann Thorac Surg. 2006 Mar;81(3):1076-81.

PMID:
16488726
12.

Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.

Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV.

Acta Oncol. 2012 May;51(5):636-44. doi: 10.3109/0284186X.2011.643822. Epub 2012 Jan 2.

PMID:
22208782
13.

Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma.

Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, Higuchi I, Hatazawa J, Mori M, Doki Y.

Surgery. 2010 Nov;148(5):908-18. doi: 10.1016/j.surg.2010.02.016. Epub 2010 Apr 7.

PMID:
20378140
14.

Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.

Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ.

Cancer. 2007 Jan 1;109(1):125-34.

PMID:
17146785
15.

[Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer].

Wang X, Peng G, Zhang X, Chen Z, Zhang B, Li Z.

Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Mar;18(3):232-7. Chinese.

PMID:
25809325
16.

High False Positivity in Positron Emission Tomography is a Potential Diagnostic Pitfall in Patients with Suspected Adrenal Metastasis.

Lang BH, Cowling BJ, Li JY, Wong KP, Wan KY.

World J Surg. 2015 Aug;39(8):1902-8. doi: 10.1007/s00268-015-3035-3.

PMID:
25809060
17.

Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.

McDonough PB, Jones DR, Shen KR, Northup PG, Galysh RL, Hernandez A, White GE, Kahaleh M, Shami VM.

Am J Gastroenterol. 2008 Mar;103(3):570-4. Epub 2007 Oct 17.

PMID:
17941963
18.

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.

J Nucl Med. 2007 Aug;48(8):1251-8. Epub 2007 Jul 13.

PMID:
17631554
19.

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

Räsänen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, Viljanen T, Salo JA.

Ann Surg Oncol. 2003 Oct;10(8):954-60.

PMID:
14527917
20.

Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

Sepesi B, Raymond DP, Polomsky M, Watson TJ, Litle VR, Jones CE, Hu R, Qiu X, Peters JH.

J Gastrointest Surg. 2009 Dec;13(12):2121-7. doi: 10.1007/s11605-009-1038-9. Epub 2009 Oct 1.

PMID:
19795177

Supplemental Content

Support Center